EmendoBio Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
EmendoBio is a biotechnology research company focused on developing next-generation gene editing tools to address genetic disorders and overcome gaps that limit the realization of gene therapy. The firm applies protein engineering to craft innovative tools intended to remove bottlenecks in the field. Based in New York City, New York, it operates within the biotechnology research arena and pursues collaborations to advance gene therapy approaches. Its work is directed at enabling gene therapy research and development by providing tools for genetic disorder projects. In March 2024, EmendoBio announced a non-exclusive licensing agreement with Anocca AB to use its OMNI-A4 nuclease. The company operates with a small-to-mid-sized team.